US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biomarkers Market Research Reports & Industry Analysis

The high specificity required of biomarkers in research, drug development and clinical diagnostics creates significant diversity in the global biomarkers market. The greatest focus in biomarkers development is oncology with cancer biomarkers occupying the largest space at over 25% of the market. Biomarkers are parameters or analytes integral to or associated with a biochemical, anatomical, pathogenic, pharmacologic or molecular (genetic) process of clinical interest.

Biomarker discovery continues to power the development of in vitro diagnostic (IVD) tests used to diagnose disease and health conditions, predict patient response to therapy, and monitor therapeutic effects and patient health. Ideal biomarkers have excellent sensitivity and specificity in terms of identifying disease, determining disease state, or evaluating patient response to therapy. Biomarkers are generally proteins (products of gene expression) or nucleic acid sequences (either RNA or DNA); small molecules that are products of metabolism may also serve as biomarkers.

The proliferation of biomarkers is a result of greater clinical understanding of the interconnections between genetics, proteomics and gene expression, disease susceptibility, disease manifestation, and disease susceptibility to select therapies. Biomarkers can be classified as natural history markers (allow for the detection and isolation of a particular cell type), drug activity markers (indicate patient response to pharmological intervention), or surrogate markers (markers that can be used as an alternative to traditional endpoints such as morbidity and mortality to evaluate the effectiveness of a therapy in treating disease). Genomic research is expected to further expand the availability of biomarkers for various diseases and make significant contributions to personalized medicine.

In addition to cancer biomarkers, biomarkers are also available for cardiac function and episodes, other cardiovascular conditions, coagulation or hemostasis, endocrine function, blood sugar management, autoimmune disorders, inflammation, specific infectious diseases, sepsis, and neurological disorders. Over half of the biomarkers market exists in clinical applications, the rest in drug development, research and clinical trial applications. Biomarkers are broadly used for disease risk assessment, diagnosis, screening, treatment or therapy selection, and therapeutic monitoring.

RSS Feeds

Biomarkers Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  
Cardiac Biomarkers Market By Type (Troponin, Creatine kinase - MB (CK-MB), Natriuretic peptides - B-type Natriuretic Peptide (BNP) & N-terminal pro b-type Natriuretic peptide (NT-proBNP), Myoglobin, Ischemia Modified Albumin (IMA), Heart-type Fatty Acid B
9/5/2016 | published by: Grand View Research
... Protein (H-FABP), LDH isoenzymes), By Application (Acute Coronary Syndrome, Myocardial infarction, Congestive heart failure, Cardiomyopathy, Ischemia, Myocarditis, Atrial fibrillation), By End Use, By Region And Segment Forecasts to 2024 The cardiac biomarkers market is expected ...  |  read more...
USD 4,950
Global Neurological Biomarkers Market 2016-2020
9/8/2016 | published by: TechNavio - Infiniti Research Ltd.
... method for drug target identification. The biomarkers specifically involved in the identification of the neurological disorders are called neurological biomarkers. Technavio’s analysts forecast the global neurological biomarkers market to grow at a CAGR of 15.48% ...  |  read more...
USD 2,500
Global Renal Biomarkers Market Report 2016
8/25/2016 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Renal Biomarkers basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 2,850
Global Cancer Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022
9/1/2016 | published by: Occams Business Research & Consultancy
... from 2016 to 2022. The market growth is driven by factors such as increasing prevalence of cancer, various technological developments in omics technologies; increased demand for personalized medicines especially in cancer therapies, rising number of ...  |  read more...
USD 3,900
Global Cell-Free DNA (cfDNA) Testing Market Analysis 2016 - Forecast to 2022
9/1/2016 | published by: Hoovers Research
... financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market ...  |  read more...
USD 4,550
Cancer Drugs with Biomarker Development: Analytical Tool
8/22/2016 | published by: BioSeeker Group AB
... from a business development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage ...  |  read more...
USD 20,250
Cardiac Marker Diagnostic Testing Markets
8/1/2016 | published by: TriMark Publications
... cardiac arrest (SCA), acute myocardial infarction (AMI), congestive heart failure (CHF) and atherosclerosis. Every year, an estimated 17 million people worldwide die from a CVD. This TriMark Publications report describes the specific market segment of ...  |  read more...
USD 5,500
MicroRNAs in Cancer Drug Pipeline Update
8/4/2016 | published by: BioSeeker Group AB
... minimal toxicities either as a monotherapy or perhaps even more likely in a combinatorial drug setting. miRNA may also hold great potential as biomarkers, albeit a lot of work is a head of us and ...  |  read more...
USD 6,750
Biomarkers Market Analysis By Type (Safety, Efficacy, Validation), By Application (Diagnostics, Drug Development, Personalized Medicine), By Disease (Oncology, Cardiovascular, Neurology, Immunology) And Segment Forecasts To 2024
8/2/2016 | published by: Grand View Research
... over USD 78.2 billion by 2024, according to a new report by Grand View Research, Inc. The growing demand for companion diagnostics and the rising adoption of personalized medicine are the key factors propelling the ...  |  read more...
USD 4,700
Global Metabolomic Technology Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022
8/8/2016 | published by: Occams Business Research & Consultancy
... CAGR of 30.5% during 2016-2022. The metabolomics technology market is segmented on the basis of application, technique, indication and geography. The application segment is segmented into discovery & drug assessment, toxicology testing, biomarker discovery, nutrigenomics, ...  |  read more...
USD 3,900
Global MicroRNA Tools and Services Market Analysis 2016 - Forecast to 2022
8/1/2016 | published by: Hoovers Research
... financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market ...  |  read more...
USD 4,550
Global Cardiac Markers Market Analysis 2016 - Forecast to 2022
8/1/2016 | published by: Hoovers Research
... derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which ...  |  read more...
USD 4,550
Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate, Liver), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA), Product (Instruments, Software), End User (Reference Laboratory, Research Centers) - Forecast to 2021
7/21/2016 | published by: MarketsandMarkets
... for Research on Liquid Biopsy and Technological Advancements to Boost the Growth of the Liquid Biopsy Market The liquid biopsy market is expected to reach USD 1.66 billion by 2021 from USD 0.58 billion in ...  |  read more...
USD 5,650
Immunodiagnostics: Spot Fast-Growing Market Segments - Therapeutic Drug Monitoring (TDM), Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse
8/2/2016 | published by: VPGMarketResearch.com
... trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares features ...  |  read more...
USD 24,500
MicroRNA Tools and Services Market
5/3/2016 | published by: Kalorama Information
... to clinical applications. The report includes the following market information: Estimated Market Breakdown by Tools and Services, 2015 Estimated Market Breakdown by Geographic Region, 2015 (North America, Europe, ROW) Global Revenues and Forecast for the ...  |  read more...
USD 4,200
Cardiac Markers
6/16/2016 | published by: Kalorama Information
... of Cardiovascular Disease Selected Biomarkers and Biomarker Panels for Cardiovascular Disease, and Companies Developing/Marketing These Biomarkers Selected Lipid Biomarkers, and Companies Developing/Marketing These Biomarkers Biomarkers are biological or biochemical molecules, or genetic changes, or other ...  |  read more...
USD 1,995
Growth Potential of Specific Biomarker-Based Tests: White Paper
2/9/2016 | published by: Kalorama Information
... for all tests are provided, as well as a list of companies that are involved in the market.  Markers discussed include:  CEA, HIV Rapid Marker-Based, AFP, FOB, Rapid PSA, NMP22, Cardiac Markers-Acute, C difficile Marker-Based, ...  |  read more...
Biomarker-Based Tests: Faster Revenue Growth
2/26/2016 | published by: Kalorama Information
Tests with biomarker basis are demonstrating faster revenue growth than the IVD market.  This White Paper discusses the trend, and defines companies in the marketplace.  Based on Kalorama Informaton's Biomarker Market reporting.    |  read more...
The Global Market for Biomarkers (Cancer Markers, Cardiac Markers, Immunological Disease Markers, Infectious Disease Markers, Others)
12/10/2015 | published by: Kalorama Information
... markets for biomarkers. The report provides a market analysis for six broad areas of medical biomarkers: The Market for Cancer Biomarkers The Market for Cardiovascular Disease Biomarkers The Market for Immunological Disease Biomarkers The Market ...  |  read more...
USD 4,200
Biomarkers: Technologies and Global Markets
6/1/2016 | published by: BCC Research
... (CAGR) of 13.8% from 2015 to 2020, increasing from $50.6 billion in 2015 to $96.6 billion in 2020. This report provides: An overview of the global markets for biomarkers. Analyses of global market trends, with ...  |  read more...
USD 6,650
Cancer Biomarkers Market outlook - Market size, segmentation, market share and competitive landscape (2016-2021)
6/1/2016 | published by: Mordor Intelligence LLP
... billion by 2019, growing at a CAGR of 14.60% during the forecast period 2011 to 2019. Biomarkers are chemical, physical or biological parameters which can be used to indicate disease states. Cancer biomarkers offers high ...  |  read more...
USD 500
Global Central Nervous System (CNS) Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022
6/5/2016 | published by: Occams Business Research & Consultancy
... or progress of effects of treatment. It helps in understanding various chronic diseases, its effects on exposure to certain environmental conditions and also in identification of people who are at high risk of developing the ...  |  read more...
USD 3,900
CD19 Therapeutics Market, 2016 - 2030
3/31/2016 | published by: Roots Analysis
... an immune response. Immunotherapies exploit the body's innate potential to specifically target a particular molecular antigen and mount an efficient immune response against the cells bearing the diseased signature. Currently, four major types of immunotherapies ...  |  read more...
USD 2,199
Cardiac Biomarkers (Clinical Laboratory Testing, Point-of-Care Testing (POCT), Acute myocardial infarction (AMI), etc.)
4/1/2016 | published by: Global Industry Analysts
... of Care Testing. The Global, US and European markets are further analyzed by the following Test Types: Cardiac Troponin, BNP and NT-proBNP, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, ...  |  read more...
USD 4,500
Cardiac Biomarkers: Technologies and Global Markets
6/1/2016 | published by: BCC Research
... growth rate (CAGR) of 12.4% from 2015 to 2020, increasing to over $8.8 billion in 2020. This report provides: An overview of the global market for cardiac biomarkers and related technologies. Analyses of global market ...  |  read more...
USD 6,650
< prev 1    3  4  5  6  7  8  9